Literature DB >> 10331677

Assessment: Neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

G M Fenichel1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10331677     DOI: 10.1212/wnl.52.8.1546

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Frequent vaccination and immune complex deposition in unilateral nephrectomized mice.

Authors:  Semra Kurul; Salih Kavukcu; Banu Sis; Osman Yilmaz; Sulen Sarioglu; Alper Soylu; Mehmet Turkmen; Eray Dirik
Journal:  Pediatr Nephrol       Date:  2004-03-20       Impact factor: 3.714

Review 2.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

3.  Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland.

Authors:  Bettina Ute Tillmann; Hanns-Christian Tillmann; Ulrich Heininger; Jürg Lütschg; Peter Weber
Journal:  Eur J Pediatr       Date:  2005-02-25       Impact factor: 3.183

4.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

5.  Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.

Authors:  Pedro L Moro; Emily Jane Woo; Wendy Paul; Paige Lewis; Brett W Petersen; Maria Cano
Journal:  PLoS Negl Trop Dis       Date:  2016-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.